Interferon beta-1b for COVID-19
- PMID: 32401712
- PMCID: PMC7211497
- DOI: 10.1016/S0140-6736(20)31101-6
Interferon beta-1b for COVID-19
Figures
Comment on
-
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.Lancet. 2020 May 30;395(10238):1695-1704. doi: 10.1016/S0140-6736(20)31042-4. Epub 2020 May 10. Lancet. 2020. PMID: 32401715 Free PMC article. Clinical Trial.
Similar articles
-
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.Lancet. 2020 May 30;395(10238):1695-1704. doi: 10.1016/S0140-6736(20)31042-4. Epub 2020 May 10. Lancet. 2020. PMID: 32401715 Free PMC article. Clinical Trial.
-
Early triple antiviral therapy for COVID-19.Lancet. 2020 Nov 7;396(10261):1487-1488. doi: 10.1016/S0140-6736(20)32274-1. Lancet. 2020. PMID: 33160566 Free PMC article. No abstract available.
-
Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b.Int J Antimicrob Agents. 2020 Aug;56(2):106052. doi: 10.1016/j.ijantimicag.2020.106052. Epub 2020 Jun 13. Int J Antimicrob Agents. 2020. PMID: 32544570 Free PMC article. No abstract available.
-
BET 1: Lopinavir-ritonavir and COVID-19.Emerg Med J. 2020 Jul;37(7):450-451. doi: 10.1136/emermed-2020-210221.2. Emerg Med J. 2020. PMID: 32616658 Review. No abstract available.
-
[Potential therapeutic drugs for novel coronavirus pneumonia].Zhonghua Jie He He Hu Xi Za Zhi. 2020 Nov 12;43(11):970-974. doi: 10.3760/cma.j.cn112147-20200226-00191. Zhonghua Jie He He Hu Xi Za Zhi. 2020. PMID: 33137863 Review. Chinese.
Cited by
-
Is there sufficient evidence to support the health benefits of including donkey milk in the diet?Front Nutr. 2024 Sep 25;11:1404998. doi: 10.3389/fnut.2024.1404998. eCollection 2024. Front Nutr. 2024. PMID: 39385792 Free PMC article. Review.
-
Modulation of Human Macrophages by Plasma from COVID-19 Patients Following BCG Vaccination: BATTLE Trial.Int J Gen Med. 2024 Jul 16;17:3107-3117. doi: 10.2147/IJGM.S468047. eCollection 2024. Int J Gen Med. 2024. PMID: 39049828 Free PMC article.
-
Bovine colostrum and its potential contributions for treatment and prevention of COVID-19.Front Immunol. 2023 Oct 16;14:1214514. doi: 10.3389/fimmu.2023.1214514. eCollection 2023. Front Immunol. 2023. PMID: 37908368 Free PMC article. Review.
-
Systemic Review and Meta-Analysis to Evaluate Therapeutic Effectiveness of Interferon Beta-1b in Hospitalized COVID-19 Patients.Indian J Community Med. 2023 May-Jun;48(3):390-400. doi: 10.4103/ijcm.ijcm_577_22. Epub 2023 May 30. Indian J Community Med. 2023. PMID: 37469907 Free PMC article. Review.
-
Defining the characteristics of interferon-alpha-stimulated human genes: insight from expression data and machine learning.Gigascience. 2022 Nov 18;11:giac103. doi: 10.1093/gigascience/giac103. Gigascience. 2022. PMID: 36399061 Free PMC article.
References
-
- WHO . World Health Organization; Geneva: April 29, 2020. Coronavirus disease 2019 (COVID-19). Situation report 100.https://www.who.int/docs/default-source/coronaviruse/situation-reports/2...
-
- Zhao Z, Zhang F, Xu M. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J Med Microbiol. 2003;52:715–720. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical